학술논문 – 부산대학교 도서관

학술논문

replay검색결과 돌아가기

search검색화면

Promising tolerability and efficacy results from dose-escalation in an ongoing phase Ib/II study of mosunetuzumab (M) with polatuzumab vedotin (Pola) in patients (pts) with relapsed/refractory (R/R) B-cell non-Hodgkin's lymphoma (B-NHL).

Document Type

Journal

Author

Budde, L. Elizabeth; Ghosh, Nilanjan; Chavez, Julio C.; Lossos, Izidore S.; Mehta, Amitkumar; Dorritie, Kathleen Anne; Kamdar, Manali K.; Negricea, Raluca; Pham, Song; Hristopoulos, Maria; Huw, Ling-Yuh; O'Hear, Carol Elaine; Oki, Yasuhiro; To, Iris; Diefenbach, Catherine S. Magid

Source

JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2021, 39 15, 3p. Supplement: S

Subject

Language

English

ISSN

15277755

Online Access

Full Text (ASCO/JCO) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일